Autoantibodies in Autoimmune Disorders: Mechanisms of Pathogenesis, Diagnostic Utility, and Therapeutic Implications
Journal Title: International Journal of Health & Medical Research - Year 2025, Vol 4, Issue 02
Abstract
Autoantibodies, once considered mere biomarkers of autoimmune disorders, are now recognized as central players in disease pathogenesis, offering critical insights into the breakdown of immune tolerance. This review synthesizes current knowledge on the dual roles of autoantibodies—as diagnostic tools and direct mediators of tissue damage—across a spectrum of autoimmune diseases. We begin by exploring the mechanisms underlying autoantibody production, including genetic predispositions (e.g., HLA haplotypes), environmental triggers (infections, microbiome dysbiosis), and dysregulated B-cell/T-cell interactions. Pathogenic mechanisms are dissected, from complement activation and immune complex deposition to receptor blockade/activation (e.g., anti-TSH receptor in Graves’ disease) and molecular mimicry. Highlighting disease-specific autoantibodies, we detail their clinical implications in systemic lupus erythematosus (anti-dsDNA, anti-Smith), rheumatoid arthritis (anti-CCP), and neurological disorders (anti-NMDA receptor, anti-AQP4). The review underscores the diagnostic and prognostic utility of autoantibodies, while addressing challenges such as seronegative autoimmunity and assay variability. Current therapeutic strategies, including B-cell depletion (rituximab), complement inhibition (eculizumab), and cytokine modulation, are evaluated alongside emerging approaches like antigen-specific tolerance induction and CAR-T cell therapy. Unresolved questions—such as why some autoantibodies remain asymptomatic and their role in disease initiation—are discussed, emphasizing the need for interdisciplinary research. Advances in single-cell technologies, proteomics, and AI-driven diagnostics promise to revolutionize personalized medicine, enabling early intervention and tailored therapies. By bridging mechanistic insights with clinical applications, this review underscores the transformative potential of autoantibody research in redefining autoimmune disease management and moving toward curative strategies.
Authors and Affiliations
Esra Hassan Abd Ali, Suzan Mohammed AbdulRaheem, Al-zahraa J. Jassim,
Keywords
Related Articles
- EP ID EP761570
- DOI 10.58806/ijhmr.2025.v4i2n03
- Views 55
- Downloads 0
The Relationship between Dietary Diversity and the Risk of Stunting in Young Children in Indonesia
Introduction: Stunting, a form of chronic malnutrition, remains a significant public health issue in Indonesia, with high prevalence rates among young children. Dietary diversity has been identified as a crucial factor i...
Management of High Frenulum Attachment in Upper Anterior Teeth: A Case Report
Introduction: Frenulum is a mucous membrane fold that attach lip and the cheek to the alveolar mucosa, gingiva, and underlying periosteum. A frenulum that extends to the gingival margin is pathogenic and indicated for re...
Mystery Turn of the Central Venous Catheter!
Anaesthesiologist and intensive care physicians are the best skilled people for placement of central venous catheter. Complications related to Central venous catheter placement have decreased by substantial number due to...
Relationship Between Stress And Alpha Amylase Levels Among Presenters
Background: Stress occurs when the internal homeostasis is disrupted by external environmental stressors. Salivary Alpha Amylase (sAA) levels are increased in response to stress, and it is frequently used as a biomarker...
Key Risk-Factors Contributing to Cardiovascular Disease: Lifestyle Modifications to Improve Cardiovascular Health
Cardiovascular disease is a preventable public health issue. The aim of this review is to identify modifiable risk-factors for cardiovascular disease and recommend lifestyle modification to prevent cardiovascular disease...